2-[2,6-bis(2-cyanophenyl)pyrimidin-4-yl]-5-(3-carbazol-9-ylcarbazol-9-yl)benzene-1,4-dicarbonitrile
C50H26N8 — CID 126735062
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[2,6-bis(2-cyanophenyl)pyrimidin-4-yl]-5-(3-carbazol-9-ylcarbazol-9-yl)benzene-1,4-dicarbonitrile
2-[2,6-bis(2-cyanophenyl)pyrimidin-4-yl]-5-(3-carbazol-9-ylcarbazol-9-yl)benzene-1,4-dicarbonitrile (PubChem CID 126735062) has the molecular formula C50H26N8 and a molecular weight of 738.81 g/mol. Its IUPAC name is 2-[2,6-bis(2-cyanophenyl)pyrimidin-4-yl]-5-(3-carbazol-9-ylcarbazol-9-yl)benzene-1,4-dicarbonitrile.
Molecular Properties
| Compound Name | 2-[2,6-bis(2-cyanophenyl)pyrimidin-4-yl]-5-(3-carbazol-9-ylcarbazol-9-yl)benzene-1,4-dicarbonitrile |
|---|---|
| PubChem CID | 126735062 |
| Molecular Formula | C50H26N8 |
| Molecular Weight | 738.81 g/mol |
| Exact Mass | 738.23 |
| IUPAC Name | 2-[2,6-bis(2-cyanophenyl)pyrimidin-4-yl]-5-(3-carbazol-9-ylcarbazol-9-yl)benzene-1,4-dicarbonitrile |
| SMILES | N#Cc1ccccc1-c1cc(-c2cc(C#N)c(-n3c4ccccc4c4cc(-n5c6ccccc6c6ccccc65)ccc43)cc2C#N)nc(-c2ccccc2C#N)n1 |
| InChI | InChI=1S/C50H26N8/c51-27-31-11-1-3-13-36(31)43-26-44(56-50(55-43)37-14-4-2-12-32(37)28-52)41-23-34(30-54)49(24-33(41)29-53)58-47-20-10-7-17-40(47)42-25-35(21-22-48(42)58)57-45-18-8-5-15-38(45)39-16-6-9-19-46(39)57/h1-26H |
| InChIKey | FWAGZQRGPBETDI-UHFFFAOYSA-N |
| XLogP | 11.16 |
| TPSA | 130.80 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 58 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 738.81 |
| LogP ≤ 5 | 11.16 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 126735062 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.